Genosaber (格诺思博)
Jiangsu, China
Genosaber, focuses on development, manufacture, sale and technical support of tumor diagnostic products. The core technology, CTC (circulating-tumor-cell) based IVD (in vitro diagnostic) targeting on Lung cancer, is one of the most promising techniques in IVD. Genosaber has received CFDA approval in 2015, which is the first CTC product been approved.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2010
- Website
- www.genosaber.com
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Genosaber (格诺思博)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now